Wang Xiaodong: insider trades.
Wang Xiaodong reported 20 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 18 sales ($24.7M), across 1 company.
- Transactions
- 20
- Purchases (P)
- 0
- Sales (S)
- 18
- Companies
- 1
- Name as filed
- Wang Xiaodong
Companies
| Company | Relationship | Transactions |
|---|---|---|
| BeOne Medicines Ltd. (ONC) | Director, Other | 20 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-28 | BeOne Medicines Ltd. | M | 31,028 | $36.9 | 31,028 | Form 4 |
| 2026-09-28 | BeOne Medicines Ltd. | S | 160 | $356.97 | 30,868 | Form 4 |
| 2026-09-28 | BeOne Medicines Ltd. | S | 120 | $358.71 | 30,748 | Form 4 |
| 2026-09-28 | BeOne Medicines Ltd. | S | 40 | $359.16 | 30,708 | Form 4 |
| 2026-09-28 | BeOne Medicines Ltd. | S | 2,241 | $361.05 | 28,467 | Form 4 |
| 2026-09-28 | BeOne Medicines Ltd. | S | 738 | $367.23 | 0 | Form 4 |
| 2026-09-28 | BeOne Medicines Ltd. | S | 3,499 | $363.1 | 20,729 | Form 4 |
| 2026-09-28 | BeOne Medicines Ltd. | S | 3,419 | $364.07 | 17,310 | Form 4 |
| 2026-09-28 | BeOne Medicines Ltd. | S | 2,047 | $365.85 | 15,263 | Form 4 |
| 2026-09-28 | BeOne Medicines Ltd. | S | 14,525 | $366.58 | 738 | Form 4 |
| 2026-09-28 | BeOne Medicines Ltd. | S | 4,239 | $362.17 | 24,228 | Form 4 |
| 2026-09-08 | BeOne Medicines Ltd. | S | 10,688 | $349.28 | 12,847 | Form 4 |
| 2026-09-08 | BeOne Medicines Ltd. | S | 7,492 | $348.31 | 23,535 | Form 4 |
| 2026-09-08 | BeOne Medicines Ltd. | M | 31,027 | $36.9 | 31,027 | Form 4 |
| 2026-09-08 | BeOne Medicines Ltd. | S | 1,181 | $345.38 | 6,079 | Form 4 |
| 2026-09-08 | BeOne Medicines Ltd. | S | 6,569 | $350.27 | 6,278 | Form 4 |
| 2026-09-08 | BeOne Medicines Ltd. | S | 1,721 | $348.01 | 0 | Form 4 |
| 2026-09-08 | BeOne Medicines Ltd. | S | 1,517 | $347.39 | 1,721 | Form 4 |
| 2026-09-08 | BeOne Medicines Ltd. | S | 2,841 | $346.16 | 3,238 | Form 4 |
| 2026-09-08 | BeOne Medicines Ltd. | S | 6,278 | $351.25 | 0 | Form 4 |
Questions
What stock did Wang Xiaodong buy or sell?
Wang Xiaodong reported 20 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 18 sales ($24.7M), across 1 company.
Is Wang Xiaodong the same person as other filers with this name?
This page covers SEC CIK 1662982 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/wang-xiaodong-1662982.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.